<SEC-DOCUMENT>0001415889-25-018145.txt : 20250624
<SEC-HEADER>0001415889-25-018145.hdr.sgml : 20250624
<ACCEPTANCE-DATETIME>20250624200232
ACCESSION NUMBER:		0001415889-25-018145
CONFORMED SUBMISSION TYPE:	144
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20250624
DATE AS OF CHANGE:		20250624

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			KALA BIO, Inc.
		CENTRAL INDEX KEY:			0001479419
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				270604595
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		144
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	001-38150
		FILM NUMBER:		251070600

	BUSINESS ADDRESS:	
		STREET 1:		1167 MASSACHUSETTS AVENUE
		CITY:			ARLINGTON
		STATE:			MA
		ZIP:			02476
		BUSINESS PHONE:		781-996-5252

	MAIL ADDRESS:	
		STREET 1:		1167 MASSACHUSETTS AVENUE
		CITY:			ARLINGTON
		STATE:			MA
		ZIP:			02476

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Kala Pharmaceuticals, Inc.
		DATE OF NAME CHANGE:	20091223

REPORTING-OWNER:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Iwicki Mark T
		CENTRAL INDEX KEY:			0001415537
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		144

	MAIL ADDRESS:	
		STREET 1:		84 WATERFORD DRIVE
		CITY:			MARLBOROUGH
		STATE:			MA
		ZIP:			01752
</SEC-HEADER>
<DOCUMENT>
<TYPE>144
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
	<headerData>
        <submissionType>144</submissionType>
                <filerInfo>
            <filer>
                <filerCredentials>
                    <cik>0001415537</cik>
                    <ccc>XXXXXXXX</ccc>
                </filerCredentials>
            </filer>
        <liveTestFlag>LIVE</liveTestFlag>




                </filerInfo>
    </headerData>

     <formData>
        <issuerInfo>
            <issuerCik>0001479419</issuerCik>
			<issuerName>KALA BIO, INC.</issuerName>


			    <secFileNumber>001-38150</secFileNumber>


			<issuerAddress>
				<com:street1>1167 MASSACHUSETTS AVENUE</com:street1>
                				<com:city>ARLINGTON</com:city>
				<com:stateOrCountry>MA</com:stateOrCountry>
				<com:zipCode>02476</com:zipCode>
			</issuerAddress>

			<issuerContactPhone>781-996-5252</issuerContactPhone>
			<nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>Mark T Iwicki</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>

			<relationshipsToIssuer>
                                				    <relationshipToIssuer>Director</relationshipToIssuer>

			</relationshipsToIssuer>
		</issuerInfo>

				          <securitiesInformation>
			<securitiesClassTitle>Common Stock</securitiesClassTitle>
			<brokerOrMarketmakerDetails>
				<name>ETRADE FINANCIAL CORPORATION</name>
				<address>
				<com:street1>3 EDISON DRIVE</com:street1>
                				<com:city>ALPHARETTA</com:city>
				<com:stateOrCountry>GA</com:stateOrCountry>
				<com:zipCode>30005</com:zipCode>
				</address>
			</brokerOrMarketmakerDetails>
			<noOfUnitsSold>13227</noOfUnitsSold>
			<aggregateMarketValue>53040.27</aggregateMarketValue>
			<noOfUnitsOutstanding>6452398</noOfUnitsOutstanding>
			<approxSaleDate>06/24/2025</approxSaleDate>
			<securitiesExchangeName>NASDAQ</securitiesExchangeName>
		</securitiesInformation>

    		       <securitiesToBeSold>
         <securitiesClassTitle>Common Stock</securitiesClassTitle>
         <acquiredDate>06/24/2025</acquiredDate>
         <natureOfAcquisitionTransaction>Restricted Stock Unit Vesting</natureOfAcquisitionTransaction>
                  <nameOfPersonfromWhomAcquired>Issuer</nameOfPersonfromWhomAcquired>
                  <isGiftTransaction>N</isGiftTransaction>
		          <amountOfSecuritiesAcquired>52952</amountOfSecuritiesAcquired>
                  <paymentDate>06/24/2025</paymentDate>
                  <natureOfPayment>Equity Compensation</natureOfPayment>
      </securitiesToBeSold>

    <nothingToReportFlagOnSecuritiesSoldInPast3Months>N</nothingToReportFlagOnSecuritiesSoldInPast3Months>


     <securitiesSoldInPast3Months>
         <sellerDetails>
            <name>Mark T Iwick</name>
            <address>
               <com:street1>1167 MASSACHUSETTS AVENUE</com:street1>
                              <com:city>ARLINGTON</com:city>
               <com:stateOrCountry>MA</com:stateOrCountry>
               <com:zipCode>02476</com:zipCode>
            </address>
         </sellerDetails>
         <securitiesClassTitle>Common Stock</securitiesClassTitle>
         <saleDate>06/03/2025</saleDate>
         <amountOfSecuritiesSold>10866</amountOfSecuritiesSold>
         <grossProceeds>40638.84</grossProceeds>
      </securitiesSoldInPast3Months>

    		<remarks>Represents the sale of shares of common stock pursuant to a "sell-to-cover" transaction in order to satisfy tax withholding obligations in connection with the vesting of RSUs previously granted to the Reporting Person. This sale was effected pursuant to an automatic sell-to-cover instruction effected pursuant to Rule 10b5-1 adopted by the Reporting Person on November 9, 2020 and does not represent a discretionary sale by the Reporting Person.</remarks>

        <noticeSignature>
            <noticeDate>06/24/2025</noticeDate>
                        <signature>  /s/ Mary Reumuth, Attorney-in-Fact</signature>
        </noticeSignature>
	</formData>
    </edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
